Literature DB >> 29553137

Cellular origin of glioblastoma and its implication in precision therapy.

Maojin Yao1, Shu Li2, Xiaojun Wu3, Shuo Diao1,4, Guoxin Zhang5, Hua He6,7, Liuguan Bian8, Yicheng Lu3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29553137      PMCID： PMC6141605          DOI： 10.1038/cmi.2017.159

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  16 in total

Review 1.  Malignant glioma: genetics and biology of a grave matter.

Authors:  E A Maher; F B Furnari; R M Bachoo; D H Rowitch; D N Louis; W K Cavenee; R A DePinho
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

2.  Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

Authors:  Paul B Chapman; Axel Hauschild; Caroline Robert; John B Haanen; Paolo Ascierto; James Larkin; Reinhard Dummer; Claus Garbe; Alessandro Testori; Michele Maio; David Hogg; Paul Lorigan; Celeste Lebbe; Thomas Jouary; Dirk Schadendorf; Antoni Ribas; Steven J O'Day; Jeffrey A Sosman; John M Kirkwood; Alexander M M Eggermont; Brigitte Dreno; Keith Nolop; Jiang Li; Betty Nelson; Jeannie Hou; Richard J Lee; Keith T Flaherty; Grant A McArthur
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

3.  Mosaic analysis with double markers in mice.

Authors:  Hui Zong; J Sebastian Espinosa; Helen Hong Su; Mandar D Muzumdar; Liqun Luo
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

4.  Generation and applications of MADM-based mouse genetic mosaic system.

Authors:  Hui Zong
Journal:  Methods Mol Biol       Date:  2014

5.  Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells.

Authors:  Pítia F Ledur; Chong Liu; Hua He; Alexandra R Harris; Darlan C Minussi; Hai-Yan Zhou; Mark E Shaffrey; Ashok Asthagiri; Maria Beatriz S Lopes; David Schiff; Yi-Cheng Lu; James W Mandell; Guido Lenz; Hui Zong
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

Review 6.  Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors.

Authors:  Rasheena Edmondson; Jessica Jenkins Broglie; Audrey F Adcock; Liju Yang
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

7.  Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes.

Authors:  Sheila R Alcantara Llaguno; Zilai Wang; Daochun Sun; Jian Chen; Jing Xu; Euiseok Kim; Kimmo J Hatanpaa; Jack M Raisanen; Dennis K Burns; Jane E Johnson; Luis F Parada
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

8.  Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype.

Authors:  Smitha Sreedharan; Naga Prathyusha Maturi; Yuan Xie; Anders Sundström; Malin Jarvius; Sylwia Libard; Irina Alafuzoff; Holger Weishaupt; Mårten Fryknäs; Rolf Larsson; Fredrik J Swartling; Lene Uhrbom
Journal:  Cancer Res       Date:  2016-11-15       Impact factor: 12.701

9.  Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.

Authors:  Lionel M L Chow; Raelene Endersby; Xiaoyan Zhu; Sherri Rankin; Chunxu Qu; Junyuan Zhang; Alberto Broniscer; David W Ellison; Suzanne J Baker
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

10.  Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy.

Authors:  Xiaoyang Lan; David J Jörg; Florence M G Cavalli; Laura M Richards; Long V Nguyen; Robert J Vanner; Paul Guilhamon; Lilian Lee; Michelle M Kushida; Davide Pellacani; Nicole I Park; Fiona J Coutinho; Heather Whetstone; Hayden J Selvadurai; Clare Che; Betty Luu; Annaick Carles; Michelle Moksa; Naghmeh Rastegar; Renee Head; Sonam Dolma; Panagiotis Prinos; Michael D Cusimano; Sunit Das; Mark Bernstein; Cheryl H Arrowsmith; Andrew J Mungall; Richard A Moore; Yussanne Ma; Marco Gallo; Mathieu Lupien; Trevor J Pugh; Michael D Taylor; Martin Hirst; Connie J Eaves; Benjamin D Simons; Peter B Dirks
Journal:  Nature       Date:  2017-08-30       Impact factor: 49.962
View more
  12 in total

1.  Genetic Hallmarks and Heterogeneity of Glioblastoma in the Single-Cell Omics Era.

Authors:  Andrea Degl'Innocenti; Nicoletta di Leo; Gianni Ciofani
Journal:  Adv Ther (Weinh)       Date:  2019-12-01

2.  Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno-Associated Viral Vector rAAV9P1.

Authors:  Amelie Bauer; Matteo Puglisi; Dennis Nagl; Joel A Schick; Thomas Werner; Andreas Klingl; Jihad El Andari; Veit Hornung; Horst Kessler; Magdalena Götz; Dirk Grimm; Ruth Brack-Werner
Journal:  Adv Sci (Weinh)       Date:  2022-04-10       Impact factor: 17.521

Review 3.  Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.

Authors:  Santiago Haase; Fernando M Nuñez; Jessica C Gauss; Sarah Thompson; Emily Brumley; Pedro Lowenstein; Maria G Castro
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 4.  MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies.

Authors:  Andrea Diana; Giuseppe Gaido; Cristina Maxia; Daniela Murtas
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 5.  Immunotherapy for glioblastoma: the promise of combination strategies.

Authors:  Mathilde Bausart; Véronique Préat; Alessio Malfanti
Journal:  J Exp Clin Cancer Res       Date:  2022-01-25

Review 6.  Neurotransmitters: Potential Targets in Glioblastoma.

Authors:  Qiqi Huang; Lishi Chen; Jianhao Liang; Qiongzhen Huang; Haitao Sun
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

7.  Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

Authors:  Wei Wu; Jessica L Klockow; Michael Zhang; Famyrah Lafortune; Edwin Chang; Linchun Jin; Yang Wu; Heike E Daldrup-Link
Journal:  Pharmacol Res       Date:  2021-07-21       Impact factor: 10.334

Review 8.  Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma.

Authors:  Mario E Lacouture; Milan J Anadkat; Matthew T Ballo; Fabio Iwamoto; Suriya A Jeyapalan; Renato V La Rocca; Margaret Schwartz; Jennifer N Serventi; Martin Glas
Journal:  Front Oncol       Date:  2020-07-28       Impact factor: 6.244

Review 9.  Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes.

Authors:  Gabriela N Debom; Dominique S Rubenich; Elizandra Braganhol
Journal:  Front Neurosci       Date:  2022-01-05       Impact factor: 4.677

Review 10.  Neuroimmunomodulatory Properties of Flavonoids and Derivates: A Potential Action as Adjuvants for the Treatment of Glioblastoma.

Authors:  Ravena Pereira do Nascimento; Balbino Lino Dos Santos; Jéssika Alves Oliveira Amparo; Janaina Ribeiro Pereira Soares; Karina Costa da Silva; Monique Reis Santana; Áurea Maria Alves Nunes Almeida; Victor Diógenes Amaral da Silva; Maria de Fátima Dias Costa; Henning Ulrich; Vivaldo Moura-Neto; Giselle Pinto de Faria Lopes; Silvia Lima Costa
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.